Crinetics Pharmaceuticals, Inc. (CRNX): $16.54

0.31 (+1.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Crinetics Pharmaceuticals Inc (CRNX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Crinetics Pharmaceuticals Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $42 $23 $32 $17.87 79.07%

The Trend in the Analyst Price Target


Over the past 106 days, CRNX's average price target has gone down $1.6.

CRNX reports an average of 126.05% for its upside potential over the past 345 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 4 42 23 32.00 17.18 86.26%
2021-04-14 5 42 23 33.60 16.42 104.63%
2021-04-10 5 42 23 33.60 17.07 96.84%
2021-04-03 5 42 23 33.60 16.00 110%
2021-03-08 5 42 23 33.60 14.62 129.82%
2021-03-06 5 42 23 33.60 15.11 122.37%
2021-02-27 5 42 23 33.60 15.29 119.75%
2021-02-20 5 42 23 33.60 16.51 103.51%
2021-02-13 5 42 23 33.60 16.21 107.28%
2021-02-06 5 42 23 33.60 15.85 111.99%
2021-01-13 5 42 23 33.60 14.12 137.96%
2021-01-09 5 42 23 33.60 15.17 121.49%
2021-01-02 5 42 23 33.60 14.11 138.13%
2020-12-26 5 42 23 33.60 13.74 144.54%
2020-12-19 5 42 23 33.60 13.14 155.71%
2020-11-23 5 40 23 32.80 12.97 152.89%
2020-11-20 5 42 23 33.60 13.66 145.97%
2020-10-26 5 40 23 32.80 12.48 162.82%
2020-09-12 4 40 30 36.75 14.96 145.66%
2020-07-25 4 40 30 36.75 14.02 162.13%
2020-07-14 4 40 30 36.75 15.21 141.62%
2020-06-29 5 40 30 36.80 17.88 105.82%
2020-05-15 5 40 35 37.80 19.70 91.88%

CRNX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 2 1 0 0 4

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRNX as an investment opportunity.

  • The upside potential (average analyst target price relative to current price) of CRNX is higher than 83.19% of all US stocks.
  • Crinetics Pharmaceuticals Inc's variance in analysts' estimates is less than 18.58% of all US stocks.
  • Crinetics Pharmaceuticals Inc's average analyst price target is greater than 71.43% of stocks in the small market cap category.
  • Crinetics Pharmaceuticals Inc's number of analysts covering the stock is greater than 34.55% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PMVP, TIL and AKUS are the three stocks most similar to Crinetics Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is CRNX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7196 seconds.